Patent Assignment
Reel/Frame 060371/0021
Assignment of Assignor's Interest
Recorded: 2022-06-30
Pages: 3
Assignee
IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) CO., LTD.
ROOM 502, 1043 HARLEY ROAD, PUDONG NEW DISTRICT, SHANGHAI, 201203, CHINA
Covered Property
(1)
NOVEL RECOMBINANT BI-FUNCTIONAL FUSION PROTEIN TARGETING CD47 AND FCyR, PREPARATION,AND USE THEROF.
Application:
16/905,262 →
Publication:
US 2021/0024598
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.